FMR1 and fragile X syndrome: Varian et al. (2022) found that oral supplementation with the anti-inflammatory probiotic Lactobacillus reuteri in outbred conventional CD-1 Swiss stock offspring mice increases FMRP levels and inhibits FXS-like phenotypes.